source
- Axiom Biosciences to launch IPO on Hong Kong exchange before Nasdaq co‑listingSan Diego‑based Axiom Biosciences announced plans to go public with a primary listing on the Hong Kong Stock Exchange, followed later by a Nasdaq co‑listing, a structure it says is a first for a U.…
- Former staff allege LifeMD prioritized GLP-1 prescription volume over patient safetyNovo Nordisk lists telehealth firm LifeMD on its website as a provider that offers legitimate medicine sourcing and patient support for individuals seeking GLP-1 drugs such as Ozempic and Wegovy.…